Literature DB >> 8798727

Secondary and tertiary structure changes of reconstituted P-glycoprotein. A Fourier transform attenuated total reflection infrared spectroscopy analysis.

N Sonveaux1, A B Shapiro, E Goormaghtigh, V Ling, J M Ruysschaert.   

Abstract

The structure of purified P-glycoprotein functionally reconstituted into liposomes was investigated by attenuated total reflection Fourier transform infrared spectroscopy. A quantitative evaluation of the secondary structure and a kinetic of 2H/H exchange of the P-glycoprotein were performed both in the presence and in the absence of MgATP, MgATP-verapamil, and MgADP. This approach was previously shown to be a useful tool to detect tertiary structure changes resulting from the interaction between a protein and its specific ligands, as established for the Neurospora crassa H+-ATPase. 2H/H exchange measurements provided evidence that a large fraction of the P-glycoprotein is poorly accessible to the aqueous medium. Addition of MgATP induced an increased accessibility to the solvent of a population of amino acids, while addition of MgATP-verapamil resulted in a subtraction of a part of the protein from access to the aqueous solvent. No significant changes were observed upon addition of MgADP or verapamil alone. The secondary structure of P-glycoprotein was not affected by addition of ligands. The variations observed in the 2H/H exchange rate when P-glycoprotein interacted with the above ligands therefore represented tertiary structure changes. Fluorescence quenching experiments confirmed that MgATP-induced changes are to be found in the tertiary structure of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798727     DOI: 10.1074/jbc.271.40.24617

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.

Authors:  H W van Veen; A Margolles; M Müller; C F Higgins; W N Konings
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2).

Authors:  A R Alexanian; N S Arutyunian
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  P-glycoprotein structure and evolutionary homologies.

Authors:  I Bosch; J M Croop
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Characterization of the 70 kDa polypeptide of the Na/Ca exchanger.

Authors:  R I Saba; A Bollen; A Herchuelz
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

5.  P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity.

Authors:  E B Mechetner; B Schott; B S Morse; W D Stein; T Druley; K A Davis; T Tsuruo; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Molecular dynamics simulations of E. coli MsbA transmembrane domain: formation of a semipore structure.

Authors:  David Y Haubertin; Hocine Madaoui; Alain Sanson; Raphaël Guérois; Stéphane Orlowski
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

Review 7.  Determination and modelling of stereoselective interactions of ligands with drug transporters: a key dimension in the understanding of drug disposition.

Authors:  P Bhatia; M Kolinski; R Moaddel; K Jozwiak; I W Wainer
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

8.  Benzodiazepine-mediated structural changes in the multidrug transporter P-glycoprotein: an intrinsic fluorescence quenching analysis.

Authors:  Sofia A C Lima; Anabela Cordeiro-da-Silva; Baltazar de Castro; Paula Gameiro
Journal:  J Membr Biol       Date:  2008-09-14       Impact factor: 1.843

Review 9.  Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

Authors:  Ahmad R Safa
Journal:  Curr Med Chem Anticancer Agents       Date:  2004-01

10.  Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.

Authors:  C Pascaud; M Garrigos; S Orlowski
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.